Tags
methicillin-resistant staphylococcus aureus, polymerase chain reaction, cost-benefit analysis, mrsa, copd, cost benefit analysis, pcr, • Methicillin resistant Staphylococcus aureus, • Meticillin resistant Staphylococcus aureus, • MRSA, • Polymerase Chain Reaction, • PCR, • Rapid Polymerase Chain Reaction, • Rapid PCR, • GeneOhm, • Xpert MRSA, • Genexpert, • Cepheid, • Cost benefit analysis, • cost-effectiveness, • economic analysis, • economic analyses, • systematic review, • clinical effectiveness